RETICULOSE Use Reported on "48 Hours"

[Wm. Bregman]

RETICULOSE Reported on CBS ³48 Hours² Being Used 
Experimentally in Treatment of Patients

Advanced Viral Research Corp., (³The Company²) (ADVR-OTC) announced today 
that the January 12, 1995 edition of the CBS Television program ³48 Hours² 
concerning alternative medicine, had reported the experimental use of
Reticulose.

Reticulose is an experimental peptide product owned and developed by 
Advanced Viral Research Corp. It is not currently approved by the FDA. 
It is being researched for clinical efficacy in several foreign countries, 
utilizing controlled scientific studies.

C.U.R.E Pharmaceuticals only has limited distribution contracts for 
registration and distribution in certain foreign countries. They are not the 
discover or redeveloper of Reticulose, or the spokesperson for Reticulose.

-- 
Wm. Bregman
Advanced Viral Research Corp.
Phone:   305-374-4847
Fax:     305-377-8241
E-Mail:  avr at ico.com